Expertise in
11
conditions

Dr. Mark A. Knautz

Dermatology
Marietta Dermatology Associates PA
111 Marble Mill Rd NW, 
Marietta, GA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
11
conditions
Marietta Dermatology Associates PA
111 Marble Mill Rd NW, 
Marietta, GA 

Overview

Mark Knautz is a Dermatologist practicing medicine in Marietta, Georgia.

Dr. Knautz is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Neurocutaneous Melanosis, Seborrheic Keratosis, Warts, and Familial Atypical Multiple Mole Melanoma Syndrome.

He is actively involved in clinical research, participating in 5 clinical trials. Dr. Knautz is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in GA

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

Marietta Dermatology Associates PA
111 Marble Mill Rd NW, Marietta, GA 30060

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3041658 in Adults With Moderate-to-Severe Hidradenitis Suppurativa
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3041658 in Adults With Moderate-to-Severe Hidradenitis Suppurativa
Enrollment Status: Completed
Publish Date: April 28, 2023
Intervention Type: Drug
Study Drug: LY3041658
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
Enrollment Status: Completed
Publish Date: February 15, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Expertise in
10
conditions
Dr. Ron J. Feldman
Dermatology
Expertise in
10
conditions
Dr. Ron J. Feldman
Dermatology
Referral required
Before you request

Emory Clinic At 1525 Clifton Road

1525 Clifton Road Northeast, Fl3, 
Atlanta, GA 
 (18.0 miles away)
404-778-3333
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ron Feldman is a Dermatologist practicing medicine in Atlanta, Georgia. Dr. Feldman is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Bullous Pemphigoid, Pemphigus Foliaceus, Pemphigus, and Pemphigus Vulgaris. Dr. Feldman is board certified in American Board Of Dermatology, 2010. Dr. Feldman is currently accepting new patients.

Expertise in
32
conditions
Expertise in
32
conditions
Referral may be required

Medical Dermatology Specialists

5730 Glenridge Drive, Suite T100, 
Sandy Springs, GA 
 (10.0 miles away)
404-939-9220
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Jamie Weisman is a Dermatologist practicing medicine in Sandy Springs, Georgia. Dr. Weisman is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Plaque Psoriasis. Dr. Weisman is board certified in American Board Of Dermatology. Dr. Weisman is currently accepting new patients.

Expertise in
13
conditions
Expertise in
13
conditions
Referral may be required
Before you request

Wellstar Medical Group LLC

5150 Stilesboro N W Rd, Suite 220, 
Kennesaw, GA 
 (8.5 miles away)
770-424-8222
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Harold Rabinovitz is a Dermatologist practicing medicine in Kennesaw, Georgia. Dr. Rabinovitz is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Melasma, Seborrheic Keratosis, and Melanoma. Dr. Rabinovitz is currently accepting new patients.

Frequently Asked Questions about Dr. Mark A. Knautz

How do I make an appointment with Dr. Mark A. Knautz?

You can book an appointment with Dr. Mark A. Knautz by calling their office at 770-479-7711. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark A. Knautz a top-rated expert for Neurocutaneous Melanosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark A. Knautz is classified as an Advanced expert for Neurocutaneous Melanosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark A. Knautz specialize in?

While Dr. Mark A. Knautz is a Dermatology, they have specific expertise in Neurocutaneous Melanosis, Seborrheic Keratosis, and Warts. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Mark A. Knautz accept my insurance?

Dr. Mark A. Knautz accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 770-479-7711 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Knautz's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 44 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile